Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

January 01, 1989; Volume 248,Issue 1

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 478;
  • You have access
    Dietary choline intake modulates benzodiazepine receptor binding and gamma-aminobutyric acidA receptor function in mouse brain.
    L G Miller, D J Greenblatt, R B Roy, F Lopez and L Wecker
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 1-6;
  • You have access
    Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced noncholinergic contraction in guinea pig bronchi.
    T D Djokic, J A Nadel, D J Dusser, K Sekizawa, P D Graf and D B Borson
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 7-11;
  • You have access
    Cholinergic receptors in renal medullary collecting duct cells.
    S McArdle, L C Garg and F T Crews
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 12-16;
  • You have access
    Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat.
    G B Corcoran and D E Salazar
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 17-22;
  • You have access
    Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
    M J Mangino, E M Brunt, P Von Doersten and C B Anderson
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 23-28;
  • You have access
    Discriminative stimulus properties of midazolam in the pigeon.
    S M Evans and C E Johanson
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 29-38;
  • You have access
    Cardioprotective effects of a new vascular intracellular calcium antagonist, KT-362, in the stunned myocardium.
    N E Farber and G J Gross
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 39-43;
  • You have access
    Effects of exogenous vasoconstrictors on coronary vascular resistance and prostacyclin production of the quiescent heart: the inhibitory effect of aspirin.
    S L Lee, S Levitsky and H Feinberg
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 44-49;
  • You have access
    Effects of buspirone and its metabolite, 1-(2-pyrimidinyl)piperazine, on brain monoamines and their metabolites in rats.
    R W Fuller and K W Perry
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 50-56;
  • You have access
    Cardiovascular effects of cocaine: enhancement by yohimbine and atropine.
    R D Wilkerson
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 57-61;
  • You have access
    Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on lipid synthesis and lipogenic enzymes in the rat.
    M R Lakshman, S J Chirtel, L L Chambers and P J Coutlakis
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 62-66;
  • You have access
    Oxidant stress stimulates active transport of serotonin by platelets.
    T R Bosin
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 67-72;
  • You have access
    [3H]-[H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2] ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain.
    K N Hawkins, R J Knapp, G K Lui, K Gulya, W Kazmierski, Y P Wan, J T Pelton, V J Hruby and H I Yamamura
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 73-80;
  • You have access
    Effects of experimental diabetes on biochemical and functional characteristics of bladder muscarinic receptors.
    J Latifpour, A Gousse, S Kondo, T Morita and R M Weiss
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 81-88;
  • You have access
    CGS 20625, a novel pyrazolopyridine anxiolytic.
    M Williams, D A Bennett, P S Loo, A F Braunwalder, C L Amrick, D E Wilson, T N Thompson, M Schmutz, N Yokoyoma and J W Wasley
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 89-96;
  • You have access
    Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
    K Bohmaker, T Puza, M Goldstein and E Meller
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 97-103;
  • You have access
    Aging: ouabain-sensitive 86Rb+ uptake rate and responsiveness to digoxin in rat left atrial muscle.
    R H Kennedy and E Seifen
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 104-110;
  • You have access
    Spontaneous regeneration of free muscarinic receptor after alkylation by BM 123. I. Recovery in vivo and in cell culture.
    J J Waite and D J Jenden
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 111-118;
  • You have access
    Spontaneous regeneration of free muscarinic receptor after alkylation by BM 123. II. Recovery in broken cell preparations.
    J J Waite and D J Jenden
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 119-126;
  • You have access
    Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
    S J Heishman, M L Stitzer, G E Bigelow and I A Liebson
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 127-134;
  • You have access
    Atrial natriuretic factor inhibits adrenergic and purinergic neurotransmission in the rabbit isolated vas deferens.
    J G Drewett, G J Trachte and G R Marchand
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 135-142;
  • You have access
    Effects of clinically effective concentrations of halothane on adrenergic and cholinergic synapses in rat brain in vitro.
    C W Bazil and K P Minneman
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 143-148;
  • You have access
    Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle.
    R J Winquist, L A Heaney, A A Wallace, E P Baskin, R B Stein, M L Garcia and G J Kaczorowski
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 149-156;
  • You have access
    Protection by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug, against 1,1-dichloroethylene hepatotoxicity in rats is associated with decreases in toxin metabolism and cytochrome P-450.
    M T Moslen, R F Whitehead, A E Ferguson and M F Kanz
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 157-163;
  • You have access
    Effects of McN-6186 on voltage-dependent Ca++ channels in heart and pituitary cells.
    D Rampe, A Skattebøl, D J Triggle and A M Brown
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 164-170;
  • You have access
    The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase.
    C C Felder, P A Jose and J Axelrod
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 171-175;
  • You have access
    Contribution of metabolites to the route- and time-dependent hepatic effects of di-(2-ethylhexyl)phthalate in the rat.
    G M Pollack, D D Shen and M B Dorr
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 176-181;
  • You have access
    Epitope characterization of acetaminophen bound to protein and nonprotein sulfhydryl groups by an enzyme-linked immunosorbent assay.
    D W Potter, N R Pumford, J A Hinson, R W Benson and D W Roberts
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 182-189;
  • You have access
    Immunochemical quantitation of 3-(cystein-S-yl)acetaminophen adducts in serum and liver proteins of acetaminophen-treated mice.
    N R Pumford, J A Hinson, D W Potter, K L Rowland, R W Benson and D W Roberts
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 190-196;
  • You have access
    Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    M L Cohen, W Bloomquist, J S Gidda and W Lacefield
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 197-201;
  • You have access
    Gradient in the effects of ethyl alcohol on canine gastric antral circular muscles.
    K M Sanders, J B Reed and R G Berry
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 202-207;
  • You have access
    Inhibition of gastric acid secretion in vivo and in vitro by a new calmodulin antagonist, CGS 9343B.
    E W Black, S J Strada, R L Garrett, P R Kvietys, W J Thompson and J A Norman
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 208-214;
  • You have access
    Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    G A Kopia and R E Valocik
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 215-221;
  • You have access
    Manganese-mediated increase in the rat brain mitochondrial cytochrome P-450 and drug metabolism activity: susceptibility of the striatum.
    J J Liccione and M D Maines
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 222-228;
  • You have access
    Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase.
    B Escalante, W C Sessa, J R Falck, P Yadagiri and M L Schwartzman
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 229-232;
  • You have access
    Localization and characterization of alpha-2 adrenoceptors in the isolated canine pulmonary vein.
    E H Ohlstein, S Horohonich, R J Shebuski and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 233-239;
  • You have access
    ICI 147,798: a slowly dissociable beta adrenoceptor antagonist that causes insurmountable beta-1 and surmountable beta-2 adrenoceptor antagonism in isolated tissues.
    R A Keith, T F Hwang, V S Murthy, S T Kau, A I Salama and R E Giles
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 240-248;
  • You have access
    Insurmountable beta receptor blockade by ICI 147,798 in rabbits.
    V S Murthy, T F Hwang, R Wurm, M E Zagar, R A Keith, S T Kau, A I Salama and R E Giles
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 249-255;
  • You have access
    Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
    T J Cicero, L O'Connor, B Nock, M L Adams, B T Miller, R D Bell and E R Meyer
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 256-261;
  • You have access
    Inhibition of naloxone-resistant antinociception by centrally administered H2-antagonists.
    K R Gogas and L B Hough
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 262-267;
  • You have access
    Bradykinin stimulates electrogenic bicarbonate secretion by the guinea pig gallbladder.
    A W Baird and H S Margolius
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 268-272;
  • You have access
    Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
    M S Kleven and S B Sparber
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 273-277;
  • You have access
    Effect of acute or chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats.
    C A Maggi, F Borsini, A Lecci, S Giuliani, P Meli, L Gragnani and A Meli
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 278-285;
  • You have access
    Effects of ketoprofen and indomethacin on leukocyte migration in two models of pleurisy induced by carrageenan or zymosan-activated serum in rats.
    E Vannier, M Roch-Arveiller, B Molinie, B Terlain and J P Giroud
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 286-291;
  • You have access
    Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase.
    N Frossard, K J Rhoden and P J Barnes
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 292-298;
  • You have access
    Mu and delta opioid receptors inhibit serotonin release in rat hippocampus.
    F Passarelli and T Costa
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 299-305;
  • You have access
    Beneficial effects of lidocaine and disopyramide on oxygen-deficiency-induced contractile failure and metabolic disturbance in isolated rabbit hearts.
    S Takeo, K Tanonaka, K Shimizu, K Hirai, K Miyake and R Minematsu
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 306-314;
  • You have access
    Paraxanthine metabolism in humans: determination of metabolic partial clearances and effects of allopurinol and cimetidine.
    A Lelo, G Kjellen, D J Birkett and J O Miners
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 315-319;
  • You have access
    Neocortical epileptogenesis in vitro: studies with N-methyl-D-aspartate, phencyclidine, sigma and dextromethorphan receptor ligands.
    J A Aram, D Martin, M Tomczyk, S Zeman, J Millar, G Pohler and D Lodge
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 320-328;
  • You have access
    Plasma arginine vasopressin response to intravenous methadone and naloxone in conscious dogs.
    L J Hellebrekers, W E van den Brom and J A Mol
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 329-333;
  • You have access
    Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
    M Livio, A Benigni, C Zoja, R Begnis, C Morelli, M Rossini, S Garattini and G Remuzzi
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 334-341;
  • You have access
    Interaction of the prejunctional inhibitory action of 5-hydroxytryptamine on noradrenergic transmission with neuronal amine uptake in rabbit isolated ear artery.
    A G Meehan and D F Story
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 342-347;
  • You have access
    In vivo mechanisms for the enhanced acetylation of sulfamethazine in the rabbit after hydrocortisone treatment.
    P T Reeves, R F Minchin and K F Ilett
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 348-352;
  • You have access
    Role of lipoxygenase metabolites for the hyper-responsiveness to platelet-activating factor of lungs from actively sensitized guinea pigs.
    M Pretolani, J Lefort, C Dumarey and B B Vargaftig
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 353-359;
  • You have access
    Inhibition of gentamicin-induced nephrotoxicity by pyridoxal-5'-phosphate in the rat.
    S Kacew
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 360-366;
  • You have access
    Altered responsiveness to sympathetic nerve stimulation and agonists of isolated left atria of diabetic rats: no evidence for involvement of hypothyroidism.
    N Sato, H Hashimoto, Y Takiguchi and M Nakashima
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 367-371;
  • You have access
    Effects of coronary flow, pacing rate, isoprenaline and diltiazem on ischemic ventricular arrhythmias in guinea pig hearts.
    S C Dennis, W A Coetzee, J W de Jong, W Clusin and L H Opie
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 372-377;
  • You have access
    Cholecystokinin, but not gastrin, induces gamma-aminobutyric acid release from myenteric neurons of the guinea pig ileum.
    I Sano, K Taniyama and C Tanaka
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 378-383;
  • You have access
    Contractile actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: structure-activity relationships and comparison with the effects of human transforming growth factor-alpha.
    M D Hollenberg, I Muramatsu, H Itoh, P Patel, S G Yang and K Lederis
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 384-390;
  • You have access
    Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    W P Burkard, E P Bonetti, M Da Prada, J R Martin, P Polc, R Schaffner, R Scherschlicht, F Hefti, R K Müller and P C Wyss
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 391-399;
  • You have access
    Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
    M Da Prada, R Kettler, H H Keller, W P Burkard, D Muggli-Maniglio and W E Haefely
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 400-414;
  • You have access
    In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
    E Somekh, D Douer, N Shaked and E Rubinstein
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 415-418;
  • You have access
    Neuronal uptake and metabolism of 2- and 6-fluorodopamine: false neurotransmitters for positron emission tomographic imaging of sympathetically innervated tissues.
    G Eisenhofer, D Hovevey-Sion, I J Kopin, R Miletich, K L Kirk, R Finn and D S Goldstein
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 419-427;
  • You have access
    Renal clearance of substituted hippurates in the dog. I. Benzoylglycine (hippurate) and methyl-substituted benzoylglycines.
    F G Russell, A C Wouterse and C A van Ginneken
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 428-435;
  • You have access
    Renal clearance of substituted hippurates in the dog. II. 4-Amino-, hydroxy- and methoxy-substituted benzoylglycines.
    F G Russel, A C Wouterse and C A van Ginneken
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 436-446;
  • You have access
    Morphine, capsaicin and K+ release purines from capsaicin-sensitive primary afferent nerve terminals in the spinal cord.
    M I Sweeney, T D White and J Sawynok
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 447-454;
  • You have access
    Calcitonin gene-related peptide and vasodilator nerves in large cerebral arteries of cats.
    A Saito, T Masaki, Y Uchiyama, T J Lee and K Goto
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 455-462;
  • You have access
    Electrophysiological actions of Ro5-4864 on cerebellar Purkinje neurons: evidence for "peripheral" benzodiazepine receptor-mediated depression.
    A S Basile, G T Bolger, H W Lueddens and P Skolnick
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 463-469;
  • You have access
    Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
    G E Duncan, I A Paul, K R Powell, J B Fassberg, W E Stumpf and G R Breese
    Journal of Pharmacology and Experimental Therapeutics January 1989, 248 (1) 470-477;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 248, Issue 1
1 Jan 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Read
Loading
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Nose-to-Brain Delivery
  • Interaction between Bupropion and MDMA
  • Smoking Could Worsen COVID-19 Outcome
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics